-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VYd/db4Nrngdxt+PsqA2FRP/+epP/DhVM4gg7FNhcdBsHEoZvAFJTnfWszdZfI+G nlXtWLBT4u+Okg5qIBd64w== 0001266068-04-000050.txt : 20040331 0001266068-04-000050.hdr.sgml : 20040331 20040330195128 ACCESSION NUMBER: 0001266068-04-000050 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031231 FILED AS OF DATE: 20040331 EFFECTIVENESS DATE: 20040331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KAIRE HOLDINGS INC CENTRAL INDEX KEY: 0000822997 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133367421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21384 FILM NUMBER: 04703471 BUSINESS ADDRESS: STREET 1: 552 SESPE AVENUE "D" CITY: FILLMORE STATE: CA ZIP: 93015 BUSINESS PHONE: 8055240024 MAIL ADDRESS: STREET 1: 552 SESPE AVENUE "D" CITY: FILLMORE STATE: CA ZIP: 93015 FORMER COMPANY: FORMER CONFORMED NAME: INTERACTIVE MEDICAL TECHNOLOGIES LTD DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: INTERACTIVE PRINCIPLES LTD DATE OF NAME CHANGE: 19900419 NT 10-K 1 body.htm KAIRE HOLDINGS FORM 12B25 DEC 31, 2003 Kaire Holdings Form 12b25 Dec 31, 2003

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25
NOTIFICATION OF LATE FILING

OMB APPROVAL
OMB Number 3235-0058
Expires March 31, 2006
Estimated average burden
hours per response.2.50

SEC FILE NUMBER
0-21384
CUSIP NUMBER
483003 10 9



Check One:  [X ]Form 10-K [ ]Form 20-F [ ]Form 11-K [ ]Form 10-Q [ ]Form N-SAR
For Period Ended: December 31, 2003
[ ]Transition Report on Form 10-K
[ ]Transition Report on Form 20-F
[ ]Transition Report on Form 11-K
[ ]Transition Report on Form 10-Q
[ ]Transition Report on Form N-SAR
For the Transition Period Ended: _______________________________

_________________________________________________________________
PART I -- REGISTRANT INFORMATION
_________________________________________________________________
Full Name of Registrant

KAIRE HOLDINGS INCORPORATED
_________________________________________________________________
Address of Principal Executive Office (Street and Number)

5520 Sespe Ave. Suite D
________________________________________________________________
City, State and Zip Code

Fillmore, CA 93015


________________________________________________________________

PART II -- Rules 12b-25(b) and (c)
________________________________________________________________


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to 12b-25(b) [Paragraph 23,047], the following should be completed.  (Check box if appropriate.)  [X]
  
    (a)  The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    (b)  The subject annual report, semiannual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, 
           will be filed on or before the fifteenth calendar day following the prescribed due date or the subject quarterly report of
           transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the 
           prescribed due date; and
    (c)  The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.


_________________________________________________________________
PART III -- NARRATIVE
_________________________________________________________________ 
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report, or portion thereof, could not be filed within the prescribed time period.

The 2003 audit will be completed around April 5, 2004.
 
 
________________________________________________________________
PART IV -- OTHER INFORMATION
_________________________________________________________________
(1)  Name and telephone number of person to contact in regard to this notification.

Owen Naccarato                  949      851-9261
________________________________________________________
(Name)                  & nbsp;              (Area Code)                 (Telephone Number)
_______________________________________________________________

(2)  Have all other periodic reports under Section 13 or 15(d) of the Securities Exchange Act of 1934 ("Exchange Act") or Section 30 of the Investment Company Act of 1940 during the preceding twelve months (or for such shorter period that the registrant was required to filer such reports) been filed?
                                                             &nbs p;                                                      [X] YES [ ] NO
If the answer is no, identify reports.
________________________________________________________________

 

(3)  Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report, or portion thereof?
                                                                                              &n bsp;                    [ ] YES [X] NO
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
_______________________________________________________________


 
     

 
 
KAIRE HOLDINGS INCORPORATED

(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
 
 
Date: March 31, 2004
By
/s/    Steven Westlund
Steven Westlund
CEO
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

-----END PRIVACY-ENHANCED MESSAGE-----